JLR Commentaries

Subscribe to collection
FilterHide Filter
  • Commentary
    Open Access

    COVID-19: lipid disruption is pushing the envelope

    Journal of Lipid Research
    Vol. 63Issue 7100240Published online: June 10, 2022
    • Garret A. FitzGerald
    Cited in Scopus: 0
      A plethora of articles have been published on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and science has delivered, given the rapid development of vaccines and of novel antiviral therapeutics evaluated for their efficacy efficiently in platform trials. An unfolding story of interferon genetics and autoantibodies has begun to help us parse the reasons for varied susceptibility to severe disease and sequencing, and tracking at a global level has allowed for the rapid detection of new variants as they emerge.

    ASBMB  ASBMB  ASBMB  ASBMB

    ISSN 0022-2275
    We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
    Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


    RELX